
Conference Coverage
about 1 hour ago
3 New Study Findings to Look Out for at Menopause Society 2025about 15 hours ago
ESMO Panel Takes on Challenges, Opportunities in AYA Cancer Survivorshipabout 17 hours ago
Phenotyping Could Be Useful Tool in Diagnosing HFpEFLatest Content

3 New Study Findings to Look Out for at Menopause Society 2025

KEYNOTE-905 Paves the Way for Next Generation of MIBC Trials: Christof Vulsteke, MD, PhD

Comprehensive Eye Exams Key for MG-Related Vision Changes

Adding Radioligand Therapy Pluvicto to SOC Cuts Risk of Prostate Cancer Progression or Death 28%, but How Many Doses?

Body Size, Metabolism Impact Psoriasis Severity and Biologic Response

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

The 7-mg and 14-mg oral semaglutide tablets are now indicated to reduce the risk of major adverse cardiovascular events in adults with diabetes.

Telehealth abortion requests doubled after the Dobbs decision, especially for those far from clinics or seeking care before 6 weeks of pregnancy.

Tezepelumab (Tezspire) improves symptoms, reduces surgery needs, and lowers steroid use in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

Experts at the European Society for Medical Oncology Congress meeting in Berlin, Germany, explore rising cancer rates in young adults, focusing on survivorship challenges and the role of lifestyle interventions in care.

Medicare expenditures for patients with amyotrophic lateral sclerosis are more than 3 times those of the average Medicare beneficiary, and drug therapies are an important cost driver.

Phenotyping patients can help to identify potential heart failure with preserved ejection fraction (HFpEF) as well as improve patient outcomes.

Guidelines that encouraged the exposure of peanuts in children were found to significantly reduce food allergies.

A mini oral session at ESMO of targeted therapy in non-small cell lung cancer included treatments that showed effectiveness in brain metastases.

Intensivists gathered at the CHEST 2025 Annual Meeting to discuss how climate change is affecting and will affect their practice of treating pulmonary conditions.

Rebecca Dent, MD, MSc, of the National Cancer Center in Singapore, gives insights on the use of antibody-drug conjugates (ADCs) in early breast cancer treatment.